1. Home
  2. PHGE vs INTG Comparison

PHGE vs INTG Comparison

Compare PHGE & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • INTG
  • Stock Information
  • Founded
  • PHGE 2015
  • INTG 1965
  • Country
  • PHGE Israel
  • INTG United States
  • Employees
  • PHGE N/A
  • INTG N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • INTG Building operators
  • Sector
  • PHGE Health Care
  • INTG Real Estate
  • Exchange
  • PHGE Nasdaq
  • INTG Nasdaq
  • Market Cap
  • PHGE 26.5M
  • INTG 30.8M
  • IPO Year
  • PHGE N/A
  • INTG N/A
  • Fundamental
  • Price
  • PHGE $0.49
  • INTG $13.98
  • Analyst Decision
  • PHGE Strong Buy
  • INTG
  • Analyst Count
  • PHGE 2
  • INTG 0
  • Target Price
  • PHGE $22.50
  • INTG N/A
  • AVG Volume (30 Days)
  • PHGE 159.9K
  • INTG 5.8K
  • Earning Date
  • PHGE 11-14-2024
  • INTG 11-13-2024
  • Dividend Yield
  • PHGE N/A
  • INTG N/A
  • EPS Growth
  • PHGE N/A
  • INTG N/A
  • EPS
  • PHGE N/A
  • INTG N/A
  • Revenue
  • PHGE N/A
  • INTG $59,536,000.00
  • Revenue This Year
  • PHGE N/A
  • INTG N/A
  • Revenue Next Year
  • PHGE N/A
  • INTG N/A
  • P/E Ratio
  • PHGE N/A
  • INTG N/A
  • Revenue Growth
  • PHGE N/A
  • INTG 4.95
  • 52 Week Low
  • PHGE $0.49
  • INTG $13.65
  • 52 Week High
  • PHGE $8.55
  • INTG $28.85
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 21.78
  • INTG 40.63
  • Support Level
  • PHGE $0.56
  • INTG $14.18
  • Resistance Level
  • PHGE $0.79
  • INTG $14.74
  • Average True Range (ATR)
  • PHGE 0.10
  • INTG 0.36
  • MACD
  • PHGE -0.02
  • INTG 0.04
  • Stochastic Oscillator
  • PHGE 0.00
  • INTG 26.40

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: